Complete Story




Product Website:

Production Information: For patients with metastatic EGFR T790 mutation positive NSCLC as detected by an FDA approved test, a progression on or after TKI therapy. 

NDC Code: 00310-1350-30   80 mg  30 count

Companion Diagnostic: YES   



Limited Distribution: YES  

Manufacturer Reimbursement Assistance:

Patient Assistance (844) 275-2360 or  If there are financial barriers to fulfilling this prescription, may be able to help.

Online Information:


Direct to patient nurse/clinical support program:


Additional products/supplies for patients:

Professional educational materials available from your sales specialist:

Online Information:

The best source of updated product information is your pharmaceutical sales specialist.

To identify or connect with your specialist please contact:

Brian Jenkins


Printer-Friendly Version